## Abstract Sulindac is a nonsteroidal antiinflammatory drug that has been demonstrated to be a potent chemopreventive agent against colorectal cancer in both human and animal models. __In vivo__, sulindac may be reversibly reduced to the active antiinflammatory compound, sulindac sulfide, or irrev
β¦ LIBER β¦
N-Nitroso compounds induce changes in carcinogen-metabolizing enzymes
β Scribed by Salah A. Sheweita; Mostafa H. Mostafa
- Book ID
- 116123563
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 654 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sulindac and its metabolites induce carc
β
Henry P. Ciolino; Sara E. Bass; Christopher J. MacDonald; Robert Y.S. Cheng; Gra
π
Article
π
2007
π
John Wiley and Sons
π
French
β 365 KB
Special report animal species in which n
β
P. Bogovski; S. Bogovski
π
Article
π
1981
π
John Wiley and Sons
π
French
β 309 KB
## Abstract In reviews on the carcinogenicity of Nβnitroso compounds (NC) the number of animal species in which these compounds induce cancer is understated. In recent years additional species haveβbeen used in experiments. Tumours have been induced by NC in 39 species which belong to 36 genera, 25
Carcinogenic effects of different nitros
β
Reznik, Gerd; Mohr, Ulrich; Kmoch, Norbert
π
Article
π
1975
π
Elsevier Science
π
English
β 264 KB
Chromosome aberrations induced in rat ly
β
LILLY, LORNA J.; BAHNER, BARBARA; MAGEE, P. N.
π
Article
π
1975
π
Nature Publishing Group
π
English
β 212 KB
Combined effects of complex mixtures of
β
Ole Vang; Brian F. Rasmussen; Ole Andersen
π
Article
π
1997
π
Elsevier Science
π
English
β 406 KB
Alterations in rat liver microsomal and
β
Lucier, George W.; McDaniel, Otelia S.
π
Article
π
1972
π
Elsevier Science
π
English
β 524 KB